<?xml version="1.0" ?>
<informationTable xsi:schemaLocation="http://www.sec.gov/edgar/document/thirteenf/informationtable eis_13FDocument.xsd" xmlns="http://www.sec.gov/edgar/document/thirteenf/informationtable" xmlns:n1="http://www.sec.gov/edgar/document/thirteenf/informationtable" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <infoTable>
    <nameOfIssuer>AbCellera Biologics Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>00288U106</cusip>
    <value>94412945</value>
    <shrsOrPrnAmt>
      <sshPrnamt>27525640</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>27525640</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>ACADIA Pharmaceuticals Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>004225108</cusip>
    <value>925281603</value>
    <shrsOrPrnAmt>
      <sshPrnamt>42896690</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>42896690</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Acrivon Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COMMON STOCK</titleOfClass>
    <cusip>004890109</cusip>
    <value>27143</value>
    <shrsOrPrnAmt>
      <sshPrnamt>22809</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>22809</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Agios Pharmaceuticals, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>00847X104</cusip>
    <value>6314943</value>
    <shrsOrPrnAmt>
      <sshPrnamt>189866</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>189866</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Akero Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>00973Y108</cusip>
    <value>17322257</value>
    <shrsOrPrnAmt>
      <sshPrnamt>324630</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>324630</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Aligos Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>01626L204</cusip>
    <value>598827</value>
    <shrsOrPrnAmt>
      <sshPrnamt>83055</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>83055</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Alkermes plc</nameOfIssuer>
    <titleOfClass>SHS</titleOfClass>
    <cusip>G01767105</cusip>
    <value>183407352</value>
    <shrsOrPrnAmt>
      <sshPrnamt>6410603</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>6410603</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Alumis Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>022307102</cusip>
    <value>4687500</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1562500</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1562500</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Arcellx, Inc.</nameOfIssuer>
    <titleOfClass>COMMON STOCK</titleOfClass>
    <cusip>03940C100</cusip>
    <value>10985426</value>
    <shrsOrPrnAmt>
      <sshPrnamt>166825</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>166825</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>argenx SE</nameOfIssuer>
    <titleOfClass>SPONSORED ADR</titleOfClass>
    <cusip>04016X101</cusip>
    <value>20814067</value>
    <shrsOrPrnAmt>
      <sshPrnamt>37760</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>37760</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Arrowhead Pharmaceuticals, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>04280A100</cusip>
    <value>14838949</value>
    <shrsOrPrnAmt>
      <sshPrnamt>939174</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>939174</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>BeOne Medicines Ltd.</nameOfIssuer>
    <titleOfClass>SPONSORED ADS</titleOfClass>
    <cusip>07725L102</cusip>
    <value>2129986760</value>
    <shrsOrPrnAmt>
      <sshPrnamt>8799053</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>8799053</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Bicycle Therapeutics plc</nameOfIssuer>
    <titleOfClass>SPONSORED ADS</titleOfClass>
    <cusip>088786108</cusip>
    <value>75653231</value>
    <shrsOrPrnAmt>
      <sshPrnamt>10885357</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>10885357</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>BioNTech SE</nameOfIssuer>
    <titleOfClass>SPONSORED ADS</titleOfClass>
    <cusip>09075V102</cusip>
    <value>39279232</value>
    <shrsOrPrnAmt>
      <sshPrnamt>368923</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>368923</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Blueprint Medicines Corporation</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>09627Y109</cusip>
    <value>16091461</value>
    <shrsOrPrnAmt>
      <sshPrnamt>125538</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>125538</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Candel Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>137404109</cusip>
    <value>1796867</value>
    <shrsOrPrnAmt>
      <sshPrnamt>355112</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>355112</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Celcuity Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>15102K100</cusip>
    <value>72763441</value>
    <shrsOrPrnAmt>
      <sshPrnamt>5450445</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>5450445</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Celldex Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>15117B202</cusip>
    <value>13540280</value>
    <shrsOrPrnAmt>
      <sshPrnamt>665370</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>665370</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Cerus Corporation</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>157085101</cusip>
    <value>18166220</value>
    <shrsOrPrnAmt>
      <sshPrnamt>12883844</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>12883844</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Cidara Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>171757206</cusip>
    <value>11070419</value>
    <shrsOrPrnAmt>
      <sshPrnamt>227272</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>227272</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Contineum Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>CL A</titleOfClass>
    <cusip>21217B100</cusip>
    <value>1240625</value>
    <shrsOrPrnAmt>
      <sshPrnamt>312500</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>312500</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Crinetics Pharmaceuticals, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>22663K107</cusip>
    <value>8052800</value>
    <shrsOrPrnAmt>
      <sshPrnamt>280000</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>280000</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>CytomX Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>23284F105</cusip>
    <value>7909193</value>
    <shrsOrPrnAmt>
      <sshPrnamt>3484226</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>3484226</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>DBV Technologies S.A.</nameOfIssuer>
    <titleOfClass>SPONSORED ADS</titleOfClass>
    <cusip>23306J309</cusip>
    <value>13386507</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1461425</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1461425</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Denali Therapeutics Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>24823R105</cusip>
    <value>52206413</value>
    <shrsOrPrnAmt>
      <sshPrnamt>3731695</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>3731695</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Design Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>25056L103</cusip>
    <value>5772412</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1712882</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1712882</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Dianthus Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>252828108</cusip>
    <value>14713210</value>
    <shrsOrPrnAmt>
      <sshPrnamt>789759</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>789759</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Disc Medicine, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>254604101</cusip>
    <value>17850168</value>
    <shrsOrPrnAmt>
      <sshPrnamt>337050</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>337050</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Edgewise Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>28036F105</cusip>
    <value>95780873</value>
    <shrsOrPrnAmt>
      <sshPrnamt>7305940</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>7305940</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Enliven Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>29337E102</cusip>
    <value>2303550</value>
    <shrsOrPrnAmt>
      <sshPrnamt>114833</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>114833</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Entrada Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>29384C108</cusip>
    <value>32698304</value>
    <shrsOrPrnAmt>
      <sshPrnamt>4865819</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>4865819</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Fate Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>31189P102</cusip>
    <value>2783220</value>
    <shrsOrPrnAmt>
      <sshPrnamt>2485018</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>2485018</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Generation Bio Co.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>37148K100</cusip>
    <value>622577</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1944945</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1944945</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>GRAIL, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>384747101</cusip>
    <value>83821028</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1630125</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1630125</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>HOOKIPA Pharma Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>43906K209</cusip>
    <value>1020082</value>
    <shrsOrPrnAmt>
      <sshPrnamt>812814</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>812814</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>IDEAYA Biosciences, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>45166A102</cusip>
    <value>44535663</value>
    <shrsOrPrnAmt>
      <sshPrnamt>2118728</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>2118728</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>IGM Biosciences, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>449585108</cusip>
    <value>4587755</value>
    <shrsOrPrnAmt>
      <sshPrnamt>4096210</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>4096210</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Immatics N.V.</nameOfIssuer>
    <titleOfClass>SHS</titleOfClass>
    <cusip>N44445109</cusip>
    <value>54708687</value>
    <shrsOrPrnAmt>
      <sshPrnamt>10168901</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>10168901</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Immunocore Holdings plc</nameOfIssuer>
    <titleOfClass>ADS</titleOfClass>
    <cusip>45258D105</cusip>
    <value>72884945</value>
    <shrsOrPrnAmt>
      <sshPrnamt>2322656</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>2322656</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Immunovant, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>45258J102</cusip>
    <value>87326096</value>
    <shrsOrPrnAmt>
      <sshPrnamt>5457881</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>5457881</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Incyte Corporation</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>45337C102</cusip>
    <value>2093617028</value>
    <shrsOrPrnAmt>
      <sshPrnamt>30743275</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>30743275</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Insmed Incorporated</nameOfIssuer>
    <titleOfClass>COM PAR $.01</titleOfClass>
    <cusip>457669307</cusip>
    <value>776226256</value>
    <shrsOrPrnAmt>
      <sshPrnamt>7712900</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>7712900</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Intellia Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>45826J105</cusip>
    <value>25097822</value>
    <shrsOrPrnAmt>
      <sshPrnamt>2675674</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>2675674</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>KALA BIO, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>483119202</cusip>
    <value>5721015</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1201894</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1201894</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Kiniksa Pharmaceuticals International, plc</nameOfIssuer>
    <titleOfClass>ORD SHS CL A</titleOfClass>
    <cusip>G52694109</cusip>
    <value>78158591</value>
    <shrsOrPrnAmt>
      <sshPrnamt>2824669</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>2824669</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Kodiak Sciences Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>50015M109</cusip>
    <value>64568128</value>
    <shrsOrPrnAmt>
      <sshPrnamt>17310490</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>17310490</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Kymera Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>501575104</cusip>
    <value>290268362</value>
    <shrsOrPrnAmt>
      <sshPrnamt>6651429</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>6651429</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Madrigal Pharmaceuticals, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>558868105</cusip>
    <value>598022088</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1976018</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1976018</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Merus N.V.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>N5749R100</cusip>
    <value>30212230</value>
    <shrsOrPrnAmt>
      <sshPrnamt>574377</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>574377</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Monte Rosa Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>61225M102</cusip>
    <value>22171588</value>
    <shrsOrPrnAmt>
      <sshPrnamt>4916095</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>4916095</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Neumora Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>640979100</cusip>
    <value>758672</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1034600</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1034600</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Neurogene Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>64135M105</cusip>
    <value>14825780</value>
    <shrsOrPrnAmt>
      <sshPrnamt>991691</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>991691</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Nurix Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>67080M103</cusip>
    <value>44217404</value>
    <shrsOrPrnAmt>
      <sshPrnamt>3882125</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>3882125</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Nuvalent, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>670703107</cusip>
    <value>10982393</value>
    <shrsOrPrnAmt>
      <sshPrnamt>143937</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>143937</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Opthea Limited</nameOfIssuer>
    <titleOfClass>SPONSORED ADS</titleOfClass>
    <cusip>68386J208</cusip>
    <value>0</value>
    <shrsOrPrnAmt>
      <sshPrnamt>2087320</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>2087320</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Praxis Precision Medicines, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>74006W207</cusip>
    <value>28992970</value>
    <shrsOrPrnAmt>
      <sshPrnamt>689488</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>689488</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Prelude Therapeutics Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>74065P101</cusip>
    <value>8194223</value>
    <shrsOrPrnAmt>
      <sshPrnamt>10123824</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>10123824</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Protara Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM STK</titleOfClass>
    <cusip>74365U107</cusip>
    <value>1626601</value>
    <shrsOrPrnAmt>
      <sshPrnamt>536832</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>536832</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Rapport Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>75383L102</cusip>
    <value>6254523</value>
    <shrsOrPrnAmt>
      <sshPrnamt>550090</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>550090</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Relay Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>75943R102</cusip>
    <value>4014005</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1160117</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1160117</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Replimune Group, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>76029N106</cusip>
    <value>102611171</value>
    <shrsOrPrnAmt>
      <sshPrnamt>11045336</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>11045336</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Revolution Medicines, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>76155X100</cusip>
    <value>344537320</value>
    <shrsOrPrnAmt>
      <sshPrnamt>9364972</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>9364972</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Rhythm Pharmaceuticals, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>76243J105</cusip>
    <value>354147281</value>
    <shrsOrPrnAmt>
      <sshPrnamt>5604483</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>5604483</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Rocket Pharmaceuticals, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>77313F106</cusip>
    <value>1352594</value>
    <shrsOrPrnAmt>
      <sshPrnamt>552079</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>552079</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Roivant Sciences Ltd.</nameOfIssuer>
    <titleOfClass>SHS</titleOfClass>
    <cusip>G76279101</cusip>
    <value>42462802</value>
    <shrsOrPrnAmt>
      <sshPrnamt>3767773</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>3767773</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Sagimet Biosciences Inc.</nameOfIssuer>
    <titleOfClass>COM SER A</titleOfClass>
    <cusip>786700104</cusip>
    <value>7261830</value>
    <shrsOrPrnAmt>
      <sshPrnamt>952996</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>952996</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Sana Biotechnology, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>799566104</cusip>
    <value>5544491</value>
    <shrsOrPrnAmt>
      <sshPrnamt>2030949</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>2030949</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Sera Prognostics, Inc.</nameOfIssuer>
    <titleOfClass>CLASS A COM</titleOfClass>
    <cusip>81749D107</cusip>
    <value>15229931</value>
    <shrsOrPrnAmt>
      <sshPrnamt>5498170</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>5498170</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Sionna Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>829401108</cusip>
    <value>6940000</value>
    <shrsOrPrnAmt>
      <sshPrnamt>400000</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>400000</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Skye Bioscience, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>83086J200</cusip>
    <value>6063667</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1450638</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1450638</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Spyre Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>00773J202</cusip>
    <value>9381744</value>
    <shrsOrPrnAmt>
      <sshPrnamt>626703</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>626703</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Stoke Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>86150R107</cusip>
    <value>52594061</value>
    <shrsOrPrnAmt>
      <sshPrnamt>4633838</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>4633838</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Structure Therapeutics Inc.</nameOfIssuer>
    <titleOfClass>SPONSORED ADS</titleOfClass>
    <cusip>86366E106</cusip>
    <value>52031828</value>
    <shrsOrPrnAmt>
      <sshPrnamt>2508767</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>2508767</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Summit Therapeutics Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>86627T108</cusip>
    <value>717624887</value>
    <shrsOrPrnAmt>
      <sshPrnamt>33722974</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>33722974</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Surrozen, Inc.</nameOfIssuer>
    <titleOfClass>W EXP 8/11/2026</titleOfClass>
    <cusip>86889P117</cusip>
    <value>15083</value>
    <shrsOrPrnAmt>
      <sshPrnamt>833333</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>833333</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Taysha Gene Therapies, Inc.</nameOfIssuer>
    <titleOfClass>COM SHS</titleOfClass>
    <cusip>877619106</cusip>
    <value>9250986</value>
    <shrsOrPrnAmt>
      <sshPrnamt>4004756</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>4004756</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Tectonic Therapeutic, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>878972108</cusip>
    <value>1987000</value>
    <shrsOrPrnAmt>
      <sshPrnamt>100000</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>100000</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>TScan Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>89854M101</cusip>
    <value>4037948</value>
    <shrsOrPrnAmt>
      <sshPrnamt>2784792</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>2784792</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Tyra Biosciences, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>90240B106</cusip>
    <value>101509</value>
    <shrsOrPrnAmt>
      <sshPrnamt>10607</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>10607</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Ultragenyx Pharmaceutical Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>90400D108</cusip>
    <value>100815081</value>
    <shrsOrPrnAmt>
      <sshPrnamt>2772692</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>2772692</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Vaxcyte, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>92243G108</cusip>
    <value>20835171</value>
    <shrsOrPrnAmt>
      <sshPrnamt>640885</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>640885</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Verona Pharma plc</nameOfIssuer>
    <titleOfClass>SPONSORED ADS</titleOfClass>
    <cusip>925050106</cusip>
    <value>21171071</value>
    <shrsOrPrnAmt>
      <sshPrnamt>223843</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>223843</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Verve Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>92539P101</cusip>
    <value>18995882</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1691530</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1691530</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Vir Biotechnology, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>92764N102</cusip>
    <value>2734397</value>
    <shrsOrPrnAmt>
      <sshPrnamt>542539</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>542539</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Viridian Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>92790C104</cusip>
    <value>24386796</value>
    <shrsOrPrnAmt>
      <sshPrnamt>1744406</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>1744406</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>vTv Therapeutics, Inc.</nameOfIssuer>
    <titleOfClass>CL A</titleOfClass>
    <cusip>918385204</cusip>
    <value>1459710</value>
    <shrsOrPrnAmt>
      <sshPrnamt>97314</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>97314</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Wave Life Sciences Ltd.</nameOfIssuer>
    <titleOfClass>SHS</titleOfClass>
    <cusip>Y95308105</cusip>
    <value>2236410</value>
    <shrsOrPrnAmt>
      <sshPrnamt>344063</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>344063</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Xencor, Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>98401F105</cusip>
    <value>5269588</value>
    <shrsOrPrnAmt>
      <sshPrnamt>670431</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>670431</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
  <infoTable>
    <nameOfIssuer>Xenon Pharmaceuticals Inc.</nameOfIssuer>
    <titleOfClass>COM</titleOfClass>
    <cusip>98420N105</cusip>
    <value>11587510</value>
    <shrsOrPrnAmt>
      <sshPrnamt>370208</sshPrnamt>
      <sshPrnamtType>SH</sshPrnamtType>
    </shrsOrPrnAmt>
    <investmentDiscretion>SOLE</investmentDiscretion>
    <votingAuthority>
      <Sole>370208</Sole>
      <Shared>0</Shared>
      <None>0</None>
    </votingAuthority>
  </infoTable>
</informationTable>
